King Mulltitech Global Pvt. Ltd.

Country/Region: India     State/Province: New Delhi

Main Products: Generic Drug, Generic Drug

Company Introduction
King Mulltitech Global Pvt. Ltd. is a India based company located in NEW DELHI, , known for its first in class Generic Drug. Our mission is aimed towards serving statement Generic Drug with ensuring utmost customer satisfaction. What makes us unique is our strong adherence to quality standards and ability to successfully meet the varying demands of our esteemed clients. With years of experience and expertise we excel in everything we do from manufacturing to prompt supply that led us to Canada,India,Mexico,Nigeria,United Kingdom of overall market share and annual revenue estimating around More than 6 Million US Dollar. Being a leading Generic Drug Manufacturer and Retailer we have a production facility of our own boasting 14 Years of export history and export value around US$50 Million - US$100 Million, followed by strong public relationships with years of existence in the industry. As a result, we are known for providing best quality products in most competitive rates.We operate as LLC (Limited Liability Corp) company with Agency started back in 2006 with initial business capital estimating around US$10 Million - US$50 Million. For further details Komal is available for assistance.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2006, 2006

Legal Status: Agency

Ownership: LLC (Limited Liability Corp)

Employees: Above 1000 People

Factory Size: 5, 000-10, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: BSCI

Contact Information

Contact Person: Komal

Designation: Proprietor

Department: Owner

Telephone: 91911613000000

Business Information

Main Markets: India (27%) United Kingdom (23%) Mexico (20%) Nigeria (10%) Canada (10%)

Export Focus: Canada, India, Mexico, Nigeria, United Kingdom

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: More than 6 Million US Dollar

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 71% - 80%

Payment Terms: Bank wire (T/T)

Product Showcase
Generic Drug
Generic Drug

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Health Care Supplement in India Health Care Supplement in New Delhi Generic Drug in India Generic Drug in New Delhi